Russia’s COVID-19 death toll as of February crosses 225,000 – stats service

MOSCOW (Reuters) – Russia has recorded over 225,000 deaths related to COVID-19 since the start of the pandemic in April, the Rosstat statistics service said on Friday, a figure that is more than double the death toll cited by the government coronavirus task force.

The statistics, which are reported on a monthly basis and with a lag, covering the period from April 2020 to February 2021, suggest that Russia has the third highest death toll in the world.

At 225,572, the total coronavirus-related death toll places Russia third after the United States, which has reported over 553,000 deaths, and Brazil, with over 325,000, according to data from Johns Hopkins University.

The figure is also more than double the widely-reported rolling death toll provided by the Russian government’s coronavirus task force on a daily basis.

That figure is currently at 99,633 deaths.

The authorities have said in the past that Rosstat’s figures are more complete, including data from autopsy reports not available for the daily tally.

Rosstat also provided monthly data, saying that 29,493 more people died in February this year than during the same month last year.

This marks an increase of 20.6% compared with February 2020, the last month to see no cases of coronavirus reported in Russia.

Of the total number of excess deaths in February, 24,369 were considered linked to the coronavirus, Rosstat said.

Russia recorded its first COVID-19 infection in early March 2020. The total number of cases since then recently crossed the 4.5 million mark.

(Reporting by Gleb Stolyarov; Writing by Polina Ivanova; Editing by Andrew Heavens and Marguerita Choy)

Turkey’s new daily COVID-19 cases exceed 40,000, highest level yet – ministry

ISTANBUL (Reuters) – Turkey recorded 40,806 new coronavirus cases in the last 24 hours, health ministry data showed on Thursday, the highest level since the beginning of the pandemic.

Cases have surged since the government eased measures to curb the pandemic in early March.

On Monday, President Tayyip Erdogan announced a tightening of measures, including the return of full nationwide weekend lockdowns for the Islamic fasting month of Ramadan, which starts on April 13.

The total number of cases stands at 3.358 million, the data showed. The latest daily death toll was 176, bringing the cumulative toll to 31,713.

(Reporting by Daren Butler;Editing by Elaine Hardcastle)

Merkel appeals to Germans to stay home for Easter to stem pandemic third wave

By Emma Thomasson

BERLIN (Reuters) -Chancellor Angela Merkel appealed to Germans on Thursday to stay at home over Easter and meet fewer people to help curb a third wave of the coronavirus pandemic, as the capital Berlin announced a nighttime ban on gatherings from Friday.

“It should be a quiet Easter, with those closest to you, with very reduced contact. I urge you to refrain from all non-essential travel,” Merkel said in a video message, adding this was the only way to help doctors and nurses fight the virus.

Merkel was accused of losing her grip on the COVID-19 crisis last week after she ditched plans for an extended Easter holiday agreed two days earlier with governors of Germany’s 16 states.

She has since tried to shift the blame for the third wave of the pandemic onto state premiers, accusing them of failing to stick to earlier agreements to reimpose restrictions if infections rose.

On Thursday, the city government of Berlin said it will impose a nighttime ban on gatherings from Friday and only allow children of essential workers to attend nursery from next week.

As the weather has turned warm in recent days, Berliners have been flocking to public spaces. About a hundred youngsters threw bottles and stones at police in one park on Wednesday when they tried to break up the party, the Berliner Zeitung reported.

Merkel said it was no longer the elderly who were fighting for their lives in the pandemic, but the middle-aged and even younger patients who were ending up on ventilators in hospital.

She held out hope, however, that the sluggish distribution of vaccinations would speed up after Easter, when family doctors will start giving shots.

Christian Karagiannidis, the scientific head of the DIVI association for intensive and emergency medicine, said Germany needs a two-week lockdown, faster vaccinations and compulsory tests at schools if hospitals are not to be overwhelmed.

“If this rate continues, we will reach the regular capacity limit in less than four weeks,” he told the Rheinische Post daily. “We are not over-exaggerating. Our warnings are driven by the figures.”

The Berlin city government said people would only be allowed to be outside on their own or with one other person from 9 p.m. until 5 a.m., though children under 14 are exempted.

This will be the first limited curfew imposed in Berlin since the pandemic began a year ago. The city of Hamburg already announced on Wednesday it will restrict nighttime outings from Friday, with supermarkets and takeaways shut from 9 p.m.

Unlike Britain and France, Germany’s 16 states, which run their own healthcare and security affairs, have been reluctant to impose drastic limits on movement out of fear of further damaging the economy, as well as an aversion to far-reaching restrictions on freedoms in a country wary of its Nazi past.

The number of confirmed coronavirus cases in Germany, Europe’s most populous country and largest economy, rose 24,300 to 2.833 million on Thursday, the biggest daily increase since Jan. 14. The reported death toll rose by 201 to 76,543.

(Reporting by Emma Thomasson, editing by William Maclean and Mark Heinrich)

Analysis-In mutant variants, has the coronavirus shown its best tricks?

By Kate Kelland and Julie Steenhuysen

LONDON/CHICAGO (Reuters) – The rapid rise in different parts of the world of deadly, more infectious coronavirus variants that share new mutations is leading scientists to ask a critical question – has the SARS-CoV-2 virus shown its best cards?

New variants first detected in such far-flung countries as Brazil, South Africa and Britain cropped up spontaneously within a few months late last year. All three share some of the same mutations in the important spike region of the virus used to enter and infect cells.

These include the E484k mutation, nicknamed “Eek” by some scientists for its apparent ability to evade natural immunity from previous COVID-19 infection and to reduce protection offered by current vaccines – all of which target the spike protein.

The appearance of similar mutations, independent of one another, springing up in different parts of the globe shows the coronavirus is undergoing “convergent evolution,” according to a dozen scientists interviewed by Reuters.

Although it will continue to mutate, immunologists and virologists said they suspect this coronavirus has a fixed number of moves in its arsenal.

The long-term impact for the virus’ survival, and whether a limit on the number of mutations makes it less dangerous, remains to be seen.

“It is plausible that this virus has a relatively limited number of antibody escape mutations it can make before it has played all of its cards, so to speak,” said Shane Crotty, a virologist at the La Jolla Institute for Immunology in San Diego.

That could enable drugmakers to stay on top of the virus as they develop booster vaccines directly targeting current variants, while governments struggle to tame a pandemic that has killed nearly 3 million people.

The idea that the virus could have a limited number of mutations has been circulating among experts since early February, and gathered momentum with the posting of a paper showing the spontaneous appearance of seven variants in the United States, all in the same region of the spike protein.

EVOLUTION, IN REAL TIME

The process of different species independently evolving the same traits that improve survival odds is central to evolutionary biology. The vast scope of the coronavirus pandemic – with 127.3 million infections globally – allows scientists to observe it in real time.

“If you wanted to sort of write a little textbook about viral evolution, it’s happening right now,” Dr. Francis Collins, a geneticist and director of the U.S. National Institutes of Health, said in an interview.

Scientists saw the process on a smaller scale in 2018 as a dangerous H7N9 bird flu virus in China appeared to begin adapting to human hosts. But no pathogen has evolved under such global scrutiny as SARS-CoV-2.

Wendy Barclay, a virologist and professor at Imperial College London and a member of a scientific advisory panel to the UK government, said she is struck by the “amazing amount of convergent evolution we’re seeing” with SARS-CoV-2.

“There are these infamous mutations – E484K, N501Y and K417N – which all three variants of concern are accumulating. That, added together, is very strong biology that this is the best version of this virus in the given moment,” Barclay said.

It’s not that this coronavirus is especially clever, scientists said. Each time it infects people it makes copies of itself, and with each copy it can make mistakes. While some mistakes are insignificant one-offs, the ones that give the coronavirus a survival advantage tend to persist.

“If it keeps happening over and over again, it must be providing some real growth advantage to this virus,” Collins said.

Some specialists believe the virus may have a limited number of mutations it can sustain before compromising its fitness – or changing so much it is no longer the same virus.

“I don’t think it’s going to reinvent itself with extra teeth,” said Ian Jones, a professor of virology at Britain’s University of Reading.

“If it had an unlimited number of tricks…we would see an unlimited number of mutants, but we don’t,” said Michel Nussenzweig, an immunologist at Rockefeller University in New York.

CAUTIOUS OPTIMISM

Scientists remain cautious, however, and say predicting how a virus will mutate is challenging. If there are limits on how the coronavirus can evolve, that would simplify things for vaccine developers.

Novavax Inc is adapting its vaccine to target the South African variant that in lab tests appeared to render current vaccines less effective. Chief Executive Stan Erck said the virus can only change so much and still bind to human hosts, and hopes the vaccine will “cover the vast majority of strains that are circulating.”

If not, Novavax can continue matching its vaccine to new variants, he said.

Researchers are tracking the variants through data-sharing platforms such as the Global Initiative on Sharing Avian Flu Data, which houses a huge trove of coronavirus genomes.

Scientists recently identified seven U.S. coronavirus variants with mutations all occurring in the same location in a key portion of the virus, offering more evidence of convergent evolution.

Other teams are conducting experiments that expose the virus to antibodies to force it to mutate. In many cases, the same mutations, including the infamous E484K, appeared.

Such evidence adds to cautious optimism that mutations appear to share many of the same traits.

But the world must continue tracking changes in the virus, experts said, and choke off its ability to mutate by reducing transmission through vaccinations and measures that limit its spread.

“It’s shown a very strong set of opening moves,” Vaughn Cooper, an evolutionary biology specialist at the University of Pittsburgh School of Medicine, said of this coronavirus. “We don’t know what the end game is going to look like.”

‘Falling like flies’: Hungary’s Roma community pleads for COVID help

By Marton Dunai

BUDAPEST (Reuters) – Coronavirus infections are ravaging Hungary’s 700,000-strong Roma community, according to personal accounts that suggest multiple deaths in single families are common in an unchecked outbreak fueled by deep distrust of authorities.

Data on infections in the community is unavailable but interviews with about a dozen Roma, who often live in cramped and unsanitary conditions, reveal harrowing stories of suffering and death and of huge health-care challenges.

“Our people are falling like flies,” said Aladar Horvath, a Roma rights advocate who travels widely among the community.

When asked by phone to describe the overall situation, he broke down sobbing and said he had learned an hour before that his 35-year-old nephew had died of COVID.

Another Roma, Zsanett Bito-Balogh, likened the outbreak in her town of Nagykallo in eastern Hungary to an explosion.

“It’s like a bomb went off,” she said.

“Just about every family got it…People you see riding their bikes one week are in hospital the next and you order flowers for their funerals the third.”

Bito-Balogh, who herself recovered twice from COVID-19, said that at one point she had 12 family members in hospital. She said she had lost two uncles and her grandmother to the virus in the past month, and a neighbor lost both parents, a cousin and a uncle within weeks.

She says she is now rushing to organize in-person registration points for vaccines and plans to have the network up and running in a few weeks.

Despite the challenges in persuading many Roma to turn to health authorities for medical care and vaccinations, Roma leaders are urging the government to do more to intervene and tackle what Horvath describes as a humanitarian crisis.

Prime Minister Viktor Orban’s chief of staff, Gergely Gulyas, said vaccinations would be rolled out to Roma but that the community needed to volunteer for their shots.

“Once we get to that point, the younger Roma should get in line,” Gulyas said in answer to Reuters questions. The Roma community is predominantly young, which means their vaccinations are scheduled later than for older Hungarians.

The government’s chief epidemiologist did not respond to requests for comment.

DECADES OF MISTRUST

Barely 9% of Roma want to be vaccinated against COVID-19, according to a survey carried out at Hungary’s University of Pecs in January but published here for the first time. It was conducted by Zsuzsanna Kiss, a Roma biologist and professor at Hungary’s University of Pecs.

Kiss said the Roma have mistrusted doctors and governments for decades because of perceived discrimination.

However, gaining Roma trust is not the only challenge.

Hungary’s 6,500 general practitioners are leading the vaccine roll-out, but 10% of small GP clinics are shut because there is no doctor to operate them, mostly in areas with high Roma populations, government data shows.

Although the government has deployed five “vaccination buses” that tour remote areas, people must first register for inoculations.

“The rise in cases (among the Roma) is clearly proportionate to vaccine rejection,” said former Surgeon General Ferenc Falus.

“This more infectious virus reaches a population whose immune system has weakened greatly during the winter months. If they go without vaccines for long, it will definitely show in extra infections and fatalities among the Roma.”

Hungary currently has the world’s highest weekly per capita death toll, driven by the more contagious variant first detected in Britain, despite a rapid vaccination rollout, data from Johns Hopkins University and the European Union indicates.

“We never trusted vaccines much,” said Zoltan Varga, a young Roma also from Nagykallo.

(Reporting by Marton Dunai; Editing by Mark Bendeich and Mark Heinrich)

COVID-19 third leading cause of U.S. deaths in 2020 after heart disease, cancer: U.S. report

By Vishwadha Chander

(Reuters) – COVID-19 was the primary or contributing cause of 377,883 deaths in the United States last year, with a particularly high toll among the elderly, according to a government report released on Wednesday.

The COVID-19 mortality rate made it the third leading cause of death in the United States in 2020 after heart disease and cancer, the U.S. Centers for Disease Control and Prevention (CDC) analysis found.

The CDC said that the overall U.S. mortality rate increased for the first time since 2017, by nearly 16%, to 3,358,814 deaths. The jump was driven by COVID-19, which accounted for an increase of 11.3%.

The overall death rate was lowest among children aged 5 to 14 years, and highest among people over age 85, the report found. A total of 134 children aged 14 and under died from COVID-19 in 2020, while 120,648 people aged 85 and older died from the disease. People 75-84 years old accounted for 104,212 deaths.

The COVID-19 death rate was highest among Hispanics, followed by Black non-Hispanics, the CDC’s analysis found. A total of 68,469 Hispanics died from COVID-19 and 59,871 non-Hispanic Black people died. It said 228,328 White non-Hispanics died.

The CDC report is based on death certificate data between January and December 2020.

Provisional estimates from the CDC, published last month, showed that life expectancy in the U.S. fell by a year in the first half of 2020 – the biggest decline since World War 2 – and stood at the lowest levels since 2006.

The CDC’s current analysis is based on provisional death estimates, but they provide an early indication of shifts in mortality trends, the agency said.

The CDC pointed out that limited availability of testing for the coronavirus at the beginning of the pandemic might have resulted in an underestimation of COVID-19–associated deaths.

(Reporting by Reporting by Vishwadha Chander and Caroline Humer; Editing by Bill Berkrot)

Coronavirus costs climb as Europe’s farmers seek seasonal workers

By Joan Faus and Nigel Hunt

BARCELONA/LONDON (Reuters) – Fruit and vegetable harvests are underway in western Europe with seasonal workers gathering crops in top producer Spain, but costs are rising as farmers fear a third wave of COVID-19 might cause a repeat of 2020’s damaging disruptions in labor supply.

Harvests rely heavily on workers from Africa and eastern Europe, but many couldn’t travel a year ago as borders closed in the first wave of the pandemic. Shortages of key goods appeared in supermarkets while prices rose as consumers hoarded.

Coronavirus cases are surging again in Europe, raising the risk of crop losses and adding to farmers’ costs on everything from extra transport to keep workers socially distanced to buying protective gear for seasonal laborers.

In Spain’s northeastern Catalonia region, farmer Josep Cabre said he had spent about 6,000 euros ($7,000) on masks and other protective equipment for seven seasonal workers from West Africa working on his farm picking apples, pears and peaches.

“We have been lucky and, as far as we know, none of us has contracted COVID-19,” Cabre said, adding that shutting his business for 15 days could mean a 150,000 euro loss.

“A bar or shop can close for 15 days … but if I don’t pick the fruit at its right time and I do it later it would be damaged. To stop for 15 days would be an economic disaster,” he added.

Cabre tries to give workers tasks to keep them distanced. He has stopped using a nine-seat van to take them to fields near the city of Lleida, instead using several vans and reimbursing transport costs to workers who travel alone.

Lleida saw a infection cluster last summer, partially linked to migrants seeking seasonal jobs to pick fruit.

This year, thousands of workers have arrived on chartered flights from Morocco to help gather crops in Spain for the first major harvest of strawberries in the southern Huelva province.

“COVID measures have forced us to take on more people to do the same job,” Fernando Gomez of Murcia’s Proexport growers organization said, adding that a hike in Spain’s minimum wage also put pressure on margins.

TOUGHER CHECKS

Growers in Germany still expect to have enough workers from Poland, Romania, Bulgaria and elsewhere for the asparagus harvest. But workers face tougher health and safety checks.

“The extensive corona-regulations and hygiene measures are creating great challenges, both organizational and financial,” Daniela Rixen, spokesperson for the LKSH agricultural chamber representing farmers in the German state of Schleswig-Holstein.

Bernhard Kruesken, secretary general of German national farming association DBV, said normally about 300,000 seasonal harvest workers come to Germany every year but fewer are expected in 2021 for the second year running.

France needs about 1 million seasonal workers each year. Fruit and vegetable growers have been seeking to attract local students and jobless people to compensate for lower numbers of foreigners if new travel restrictions are imposed.

Last year, France raised a so-called “shadow army” to pick crops from furloughed workers in other sectors including hotel receptionists, restaurant waiters and hairdressers.

Non-European Union workers account for about 25% of seasonal workers in France.

“You never know. At any moment rules can change and borders can be closed,” Jerome Volle, deputy-chairman of France’s largest farm lobby FNSEA said.

Similar concerns are rising in Britain, which needs about 70,000 seasonal workers with the highest demand during the berry season in late May to June.

“There is a concern that European borders end up shutting down or that people can’t travel and that will put huge pressure on the availability of seasonal workers,” said Tom Bradshaw, vice president at Britain’s National Farmers Union.

In a normal year, just 1% of the seasonal workforce comes from Britain.

Despite the challenges, there is still little likelihood of fruit shortages this year, said Natalia Aguilera, head of the Andalusian chapter of the cooperativas agro-alimentarias cooperative.

“If there weren’t any (shortages) last year, complicated as it was during the pandemic, this year there is absolutely no chance,” she said.

($1 = 0.8531 euros)

(Additional reporting by Nathan Allen in Madrid, Sybille de La Hamaide in Paris and Michael Hogan in Hamburg; Editing by Veronica Brown and Edmund Blair)

Immune response may be linked to AstraZeneca vaccine clot issue; death risk rising among young adults in Brazil

By Nancy Lapid

(Reuters) -The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

Immune response may explain rare clots after AstraZeneca vaccine

Researchers may have found an explanation for the rare but serious blood clots reported among some people who received AstraZeneca’s COVID-19 vaccine. They believe the phenomenon is similar to one that rarely occurs with a blood thinning drug called heparin, called heparin-induced thrombocytopenia (HIT). In HIT, the drug triggers the immune system to produce antibodies that activate platelets, which cause blood to clot. Drugs other than heparin can cause clotting disorders that strongly resemble HIT, and researchers suspect that in rare cases, the AstraZeneca vaccine may be another such trigger. Four previously healthy individuals who got the AstraZeneca shot and developed life-threatening clots had the same kind of antibodies that activate platelets and initiate clotting in HIT, the researchers reported on Monday in a paper posted on Research Square ahead of peer review. Twenty individuals who received the vaccine but did not develop clots did not have these antibodies. An editorial comment posted with the study noted that drug-induced thrombocytopenia is treatable if identified promptly. Millions of people have received the vaccine without issues and European regulators and the World Health Organization say the benefits of the AstraZeneca shot outweigh its risks.

COVID-19 death risk rising for young adults in Brazil

Southern Brazil is seeing a sudden rise in COVID-19 deaths among young and middle-aged adults after the identification there of a concerning virus variant known as P.1, researchers said. They analyzed data from Parana – the largest state in southern Brazil – on 553,518 cases diagnosed from September 2020 through March 17, 2021. In all age groups, the proportion of patients who died either held steady or declined between September and January. Starting in February, however, fatality rates rose for almost all groups over age 20, according to a report posted on Friday on medRxiv ahead of peer review. From January to February, these rates tripled among patients aged 20 to 29, from 0.04% to 0.13%, and doubled among those aged 30 to 39, 40 to 49, and 50 to 59. “Individuals between 20 and 29 years of age whose diagnosis was made in February 2021 had an over 3-fold higher risk of death compared to those diagnosed in January 2021,” the researchers said. “Taken together, these preliminary findings suggest significant increases in case fatality rates in young and middle-aged adults after identification of a novel SARS-CoV-2 strain circulating in Brazil, and this should raise public health alarms.”

Pfizer, Moderna vaccines limit asymptomatic infections

Vaccines from Pfizer Inc and partner BioNTech SE and from Moderna Inc dramatically reduced the risk of infection by the new coronavirus within weeks after the first of two shots, according to data from a study of nearly 4,000 U.S. healthcare personnel and first responders in six states. Previous trials by the companies evaluated the vaccines’ efficacy in preventing illness from COVID-19, but would have missed infections that did not cause symptoms. In the new study, conducted from mid-December to mid-March, nearly 75% of participants had received at least one dose of vaccine, and everyone had weekly coronavirus testing for 13 consecutive weeks in order to pick up asymptomatic infections. According to a report published on Monday by the U.S. Centers for Disease Control and Prevention (CDC), the risk of infection fell by 80% two weeks or more after the first of two shots and by 90% by two weeks after the second shot. “The authorized mRNA COVID-19 vaccines provided early, substantial real-world protection against infection for our nation’s healthcare personnel, first responders, and other frontline essential workers,” CDC Director Rochelle Walensky said in a statement.

Pandemic has cut parents’ access to hospitalized children

Pediatricians have long endorsed the idea that babies and children in hospitals should not be separated from their families – a practice that in many facilities was restricted or discontinued to limit COVID-19 infections, according to new research. From mid-May through early July, researchers collected survey responses from 96 pediatric care units in 22 countries in Europe, Asia, and North America. The results – mostly from intensive care units for newborns – showed that before the pandemic, 87% of units welcomed families and 92% encouraged skin-to-skin care, according to a report published in Journal of Perinatology. After the onset of the pandemic, more than 83% of the hospital units restricted family presence, with additional restrictions placed on parental participation in their infant’s care, said study coauthor Ita Litmanovitz of Meir Medical Center in Kfar Saba, Israel. Hospitals’ decisions to limit family access did not depend on their previous rules, the availability of single-family rooms, or the virus infection rate in the hospital’s geographical area. “Restrictions during the pandemic increased separation between the infant and family,” the researchers found. These restrictions, Litmanovitz added, “go against psychological and neuroscientific evidence in support of unrestricted parental presence and ability to care for their hospitalized infants.”

(Reporting by Nancy Lapid; Editing by Bill Berkrot)

Dying in line: Brazil’s crunch for COVID-19 intensive care beds

By Stephen Eisenhammer

PIRATININGA, Brazil (Reuters) – José Roberto Inácio spent much of his life ferrying the sick and injured to the hospital in this quiet Brazilian town.

On Wednesday, March 10, the retired ambulance driver took the familiar route once more – as a passenger gasping for breath.

By the weekend, the 63-year-old’s kidneys were failing. He needed dialysis. He needed intensive care.

But at the small hospital where he was being treated even basic medical supplies, like a catheter, were lacking. He joined the list for a bed in an intensive care unit (ICU), but doctors told his family there were 70 people in this part of Sao Paulo state already in line.

Bauru, the nearest major town, only has 50 intensive care beds – and all were full.

Inácio died waiting.

“All his life he worked to save people, but in the hour that he needed help, there was nothing for him,” Inácio’s son Roberto, 41, told Reuters, eyes still blank with shock. “You watch a person dying, and you can’t do anything about it.”

Inácio was one of 3,251 people in Brazil killed by COVID-19 on March 23, then the highest daily death toll since the pandemic began. Around the world, nearly one in three COVID-19 deaths were Brazilian. Inácio was one.

“He’s become a statistic,” his son said.

As much of the world appears to be emerging from the worst of the pandemic, Brazil’s health system is buckling.

Across the country there are over 6,000 people waiting for an ICU bed, according to government data. In 15 of Brazil’s 26 states, ICU capacity is at or above 90% full, as the country’s P1 variant fuels a second wave far deadlier than the first.

Even in Sao Paulo, Brazil’s wealthiest state with a sophisticated public hospital network, scores are dying in line for intensive care.

Despite the crisis, President Jair Bolsonaro continues to ridicule stay-at-home measures. He rarely wears a mask and has said he does not plan to get vaccinated. He told Brazilians to “stop whining” about the number of dead, now over 300,000 – the world’s second-highest toll behind the United States.

Brazil, a major global economy once lauded for its public health victories, has also been slow to secure vaccines for its 210 million inhabitants. Less than 10% of adults have received a first dose and only 3% are fully vaccinated.

Epidemiologists fear the worst is yet to come.

“This is going to be devastating,” said Albert Ko, a professor at Yale School of Public Health with decades of experience in Brazil. “Unless there’s a change in federal and state government policies, towards implementing effective lockdowns, we’re looking at a real humanitarian crisis.”

SILENT BURIAL

A giant billboard of Bolsonaro greets visitors to Bauru, a town of 400,000 about a four-hour drive from Sao Paulo.

The mayor, Suéllen Rosim, has railed against lockdown measures and aligned herself with the far-right leader. Last month, she defied a state government order to close nonessential businesses, allowing many to remain open despite surging COVID-19 cases.

A court ruling finally forced her to comply, but she continues to argue lockdowns are ineffective despite overwhelming evidence they have worked across the globe.

“There’s no science that shows that if I lock everyone up at home, everything will get better,” she told Reuters. “Bars and restaurants have been shut for weeks and the numbers haven’t stopped going up.”

She blamed the state for a lack of ICU capacity.

In response, the Sao Paulo government said it was working to increase the number of hospital beds in Bauru and across the region. The state criticized the municipality, which it said did not fund a single intensive care bed.

“The town is also responsible for the increase of intensive care and should do its part,” the state said in a note to Reuters.

On Bauru’s front line, doctors are exhausted; understaffed and under-resourced against the relentless tide of infections.

“People have been talking for months about the risk of the public health system collapsing,” said Fred Nicácio, a doctor treating COVID-19 patients in Bauru. “Sadly, that moment has come.”

Ambulances dart across town carrying patients connected to green oxygen canisters, their belongings in black trash bags by their feet.

One patient in his 40’s, between concentrated breaths, said he now understood the virus was no joke, as medics wheeled him into the hospital.

Beds are so scarce in Bauru that desperate relatives are turning to the courts, hiring lawyers to secure injunctions that would force hospitals – public or private – to take in patients.

But lawyers cannot create ICU beds where there are none. Even private hospitals are struggling, sometimes begging the public sector to take patients needing intensive care off their waitlists.

Inácio’s son is haunted by the belief that his father’s death could have been avoided. If a vaccine had reached him in time, if his hospital had an extra catheter, if an ICU bed had become available.

Last Wednesday, one week after entering the hospital he knew so well, Inácio was buried.

Four men in white hazmat suits drove his body in a minivan the two blocks to the cemetery. They carted the wooden coffin between the rows of dead to a break in the red dirt.

No words were spoken. The only sound was the scratching of mortar and brick as the tomb was sealed.

From a distance, his son watched.

(Reporting by Stephen Eisenhammer; Additional reporting by Leonardo Benassatto; Editing by Brad Haynes and Jonathan Oatis)

WHO says COVID-19 probably passed from bats to humans through another animal: AP

(Reuters) – A joint WHO-China study on the origins of COVID-19 says that the virus was probably transmitted from bats to humans through another animal, and that a lab leak was “extremely unlikely” as a cause, the Associated Press reported on Monday.

The reported findings match what WHO officials have said in the past about their conclusions following a Jan-Feb visit to China.

Many questions remain unanswered, and the team proposed further research in every area except the lab leak hypothesis, the Associated Press reported, citing a draft copy it had obtained.

WHO director-general Tedros Adhanom Ghebreysus acknowledged receipt of the report from the independent experts but declined to give details, telling a Geneva news briefing: “All hypotheses are on the table and warrant complete and further studies.”

The 400-page report, drawn up by the team which carried out a mission to the central Chinese city of Wuhan where the virus was first encountered in late 2019, is to be issued on Tuesday after diplomats from WHO’s 194 member states are briefed on its findings, Tedros said.

Germany’s international development minister Gerd Mueller, speaking to the same briefing after holding talks with Tedros, welcomed China’s cooperation with the probe.

The United States expects the WHO-led investigation to require further study of the SARS-CoV-2 virus, perhaps including a return visit to China, a senior U.S. official told reporters last week. He hoped it would be “based on science”.

The probe was plagued by delays, concern over access and bickering between Beijing and Washington, which under former U.S. President Donald Trump’s administration accused China of hiding the extent of the initial outbreak.

(Reporting by Nandakumar D in Bengaluru and Stephanie Nebehay and Emma Farge in Geneva; Editing by Himani Sarkar and Peter Graff)